XML 72 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense $ 9.4 $ 10.0 $ 29.9 $ 27.9
Cost of molecular diagnostic testing        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense 0.5 0.4 1.3 1.1
Cost of pharmaceutical and clinical services        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense 0.0 0.0 0.0 0.1
Research and development expense        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense 1.0 0.8 4.4 3.3
Selling, general, and administrative expense        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense $ 7.9 $ 8.8 $ 24.2 $ 23.4